Panacea Biotec Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Panacea Biotec zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 36.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S
Apr 04Why We Think Panacea Biotec Limited's (NSE:PANACEABIO) CEO Compensation Is Not Excessive At All
Sep 23Estimating The Fair Value Of Panacea Biotec Limited (NSE:PANACEABIO)
Jul 28How Does Panacea Biotec's (NSE:PANACEABIO) CEO Pay Compare With Company Performance?
Feb 14Introducing Panacea Biotec (NSE:PANACEABIO), A Stock That Climbed 80% In The Last Five Years
Jan 06Is Panacea Biotec (NSE:PANACEABIO) Using Too Much Debt?
Sep 17If You Had Bought Panacea Biotec (NSE:PANACEABIO) Stock A Year Ago, You Could Pocket A 78% Gain Today
Aug 03In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Panacea Biotec has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 5,516 | -117 | N/A | N/A | N/A |
9/30/2023 | 5,163 | 99 | -1,098 | -318 | N/A |
6/30/2023 | 4,784 | 334 | N/A | N/A | N/A |
3/31/2023 | 4,599 | -332 | -4,634 | -4,225 | N/A |
12/31/2022 | 4,718 | 12,164 | N/A | N/A | N/A |
9/30/2022 | 5,124 | 11,478 | -5,661 | -5,486 | N/A |
6/30/2022 | 6,395 | 10,791 | N/A | N/A | N/A |
3/31/2022 | 6,612 | 10,783 | -1,210 | -1,084 | N/A |
12/31/2021 | 6,888 | -2,137 | N/A | N/A | N/A |
9/30/2021 | 6,746 | -2,046 | 796 | 1,072 | N/A |
6/30/2021 | 6,245 | -1,704 | N/A | N/A | N/A |
3/31/2021 | 6,248 | -1,462 | 849 | 1,067 | N/A |
12/31/2020 | 5,819 | -1,604 | N/A | N/A | N/A |
9/30/2020 | 6,079 | -1,405 | 582 | 667 | N/A |
6/30/2020 | 5,510 | -1,945 | N/A | N/A | N/A |
3/31/2020 | 5,441 | -1,878 | -371 | -302 | N/A |
12/31/2019 | 5,454 | 653 | N/A | N/A | N/A |
9/30/2019 | 4,880 | 715 | -262 | -236 | N/A |
6/30/2019 | 4,832 | 482 | N/A | N/A | N/A |
3/31/2019 | 4,567 | 410 | 997 | 1,044 | N/A |
3/31/2018 | 5,928 | -716 | 1,028 | 1,180 | N/A |
3/31/2017 | 5,440 | -392 | N/A | 1,307 | N/A |
3/31/2016 | 6,531 | -183 | N/A | 907 | N/A |
3/31/2015 | 6,872 | -1,065 | N/A | 372 | N/A |
3/31/2014 | 5,100 | -1,121 | N/A | 537 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von PANACEABIO über der Sparquote liegt (6.7%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von PANACEABIO schneller wachsen werden als der Markt Indian
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von PANACEABIO in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von PANACEABIO schneller wachsen werden als der Markt von Indian.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von PANACEABIO schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von PANACEABIO in 3 Jahren voraussichtlich hoch sein wird